List view / Grid view
18 January 2019 | By Almac Group
The Almac Group, a CDMO serving the pharmaceutical and biotech sectors globally, is expanding its Edinburgh Technopole facility to allow scale-up of its personalised cancer vaccine activities...
28 November 2018 | By European Pharmaceutical Review
A clinical trial could be the world's first to look at personalised medicine in prostate cancer, with patients taking a therapy based on their DNA markers...
7 November 2018 | By Iqra Farooq (European Pharmaceutical Review)
A statistical model has been developed to calculate the success of drugs for individuals, which could lead to the availability of precision medicine...
21 September 2018 | By Iqra Farooq (European Pharmaceutical Review)
A multidisciplinary research team have developed a portable device to accurately and quickly screen people for diseases...
14 September 2018 | By Mike Stones
The FDA is seeking closer collaboration with state authorities to ensure the quality of compounded drugs and the public’s access to them...
13 September 2018 | By Iqra Farooq (European Pharmaceutical Review)
A sugar pill could benefit patients suffering from chronic pain with specific brain anatomy and psychological traits...
8 August 2018 | By SUEZ
The US FDA and European Commission have defined regulations relating to the submission of electronic records in lieu of paper documents, for submission, inspection, and archiving purposes. When ageing analytical equipment is to be replaced 21CFR Part 11 and EU Annex 11 are also topics of discussion. Common questions from…
2 July 2018 | By SCIEX
Different modalities of monoclonal antibodies are pushing the limits of characterization by MS: new critical quality attributes need to be carefully monitored from developability in early phases and then during process development and clinical phases...
14 March 2018 | By European Pharmaceutical Review
Researchers at the Moffitt Cancer Center in Florida have combined single-cell imaging of cancer cells in mice with mathematical modelling to establish which drug characteristics determine its efficacy.
15 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
A kinase inhibitor called cabozantinib could be a viable therapy option for patients with metastatic, radioactive iodine-resistant thyroid cancer...
5 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
In a new study, researchers have developed a new method for producing medicine on a white edible material containing a QR code that contains the medical drug...
11 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Scientists have developed an online interactive app to help motivate patients to be more active in managing their disease...
11 October 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
New study shows ALK inhibitor ceritinib may have the ability to be used for more than ALK-rearranged non-small cell lung cancer...
30 August 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers have found that a diabetes drug may help in certain types of Parkinson’s disease...
18 July 2017 | By Rik Van Mol | Vice President of R&D Strategy Europe | Veeva Systems
Veeva's Rik Van Mol explains how streamlining the clinical process will not only improve the speed but also the quality of the data...
Follow: